Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
D000818:Animals; D001763:Blepharoptosis / Q000139:chemically induced; D001831:Body Temperature / Q000187:drug effects; D003010:Clorgyline / Q000494:pharmacology; D003521:Cyclopropanes / Q000494:pharmacology; D006246:Harmaline / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008995:Monoamine Oxidase / Q000502:physiology*; D008996:Monoamine Oxidase Inhibitors; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D010647:Phenyl Ethers; D012110:Reserpine; D010293:Pargyline; D006246:Harmaline; D008995:Monoamine Oxidase; D003010:Clorgyline